+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 278 Pages
  • Global
From
Gaucher Disease Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 228 Pages
  • Global
From
Lysosomal Storage Diseases - Global Strategic Business Report 2026 - Product Thumbnail Image

Lysosomal Storage Diseases - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 284 Pages
  • Global
From
Fabry Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Fabry Disease Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 367 Pages
  • Global
From
Hereditary Orotic Aciduria - Global Strategic Business Report - Product Thumbnail Image

Hereditary Orotic Aciduria - Global Strategic Business Report

  • Report
  • November 2026
  • 369 Pages
  • Global
From
Hunter Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Hunter Syndrome Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 280 Pages
  • Global
From
Metabolic Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Metabolic Disorder Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 286 Pages
  • Global
From
Phenylketonuria Treatment - Global Strategic Business Report - Product Thumbnail Image

Phenylketonuria Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 184 Pages
  • Global
From
From
From
From
Acute Spinal Cord Injury Market Report 2026 - Product Thumbnail Image

Acute Spinal Cord Injury Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Gene Therapy - Global Strategic Business Report

  • Report
  • November 2026
  • 411 Pages
  • Global
From
HP (High Potency) APIs Market Report 2026 - Product Thumbnail Image

HP (High Potency) APIs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lower Respiratory Tract Therapeutics Market Report 2026 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Leukocyte Adhesion Deficiency Management Market Report 2026 - Product Thumbnail Image

Leukocyte Adhesion Deficiency Management Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Chronic Disease Markets for Sustained Released Injectables - Product Thumbnail Image

Chronic Disease Markets for Sustained Released Injectables

  • Report
  • December 2023
  • 217 Pages
  • Global
From
Glycomic Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glycomic Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 401 Pages
  • Global
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Loading Indicator